Patent · US Expired

Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them

US7462613B2 · kind B2 · utility

1Cited by

3References

14Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Swen Hölder · London, GB
Thorsten Naumann · Gedern, DE
Karl Schonafinger · Alzenau, DE
David William Will · Schwalbach, DE
Hans Matter · Langenselbold, DE
Günther Müller · Pocking, DE
Dominique Le Suisse · Montreuil, FR
Bernard Baudoin · Chaville, FR
Thomas Rooney · Oaklyn, US
Franck Halley · Sèvres, FR
Gilles Tiraboschi · Chevilly-Larue, FR
Cecile Combeau · Fontenay-aux-Roses, FR
Ingrid Sassoon · Villejuif, FR
Anke Steinmetz · Vitry-sur-Seine, FR

Key dates

Filing date	Nov 19, 2003
Grant date	Dec 9, 2008
Priority date	—
Expiry date	Nov 19, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D237/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to novel pyridazinone derivatives of the general formula (I)wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.